A mutation in myotilin causes spheroid body myopathy
Autor: | B. Azzarelli, Ruben Vidal, Hans-Hilmar Goebel, L. J. Cushman, Martin R. Farlow, Tatiana Foroud, Nathan Pankratz, H. Horak, Michael W. Pauciulo, Leticia Miravalle, William C. Nichols, A. P. Batchman |
---|---|
Rok vydání: | 2005 |
Předmět: |
Adult
Genetic Markers Male Candidate gene Pathology medicine.medical_specialty DNA Mutational Analysis Muscle Proteins Chromosome Disorders Biology Exon Muscular Diseases medicine Humans Point Mutation Myotilin Connectin Genetic Predisposition to Disease Genetic Testing Muscular dystrophy Muscle Skeletal Myopathy Aged Genes Dominant Aged 80 and over Inclusion Bodies Genetics Muscle biopsy medicine.diagnostic_test Microfilament Proteins Chromosome Mapping Exons Middle Aged medicine.disease Pedigree Cytoskeletal Proteins Mutation Chromosomal region biology.protein Chromosomes Human Pair 5 Female Titin Neurology (clinical) medicine.symptom |
Zdroj: | Neurology. 65:1936-1940 |
ISSN: | 1526-632X 0028-3878 |
DOI: | 10.1212/01.wnl.0000188872.28149.9a |
Popis: | Background: Spheroid body myopathy (SBM) is a rare, autosomal dominant, neuromuscular disorder, which has only been previously reported in a single large kindred. Identification of the mutated gene in this disorder may provide insight regarding abnormal neuromuscular function. Methods: The authors completed a detailed clinical evaluation on an extensive kindred diagnosed with SBM. Genome-wide linkage analysis was performed to localize the disease gene to a specific chromosomal region. Further marker genotyping and screening of a positional, functional candidate gene were completed to detect the disease-causing mutation. Pathologic analysis of muscle biopsy was performed on three individuals. Biochemical studies were performed on one muscle biopsy specimen from an affected individual. Results: Linkage to chromosome 5q23-5q31 was detected with a lod score of 2.9. Genotyping of additional markers in a larger sample of family members produced a maximum lod score of 6.1 and narrowed the critical interval to 12.2 cM. Screening of the candidate gene titin immunoglobulin domain protein ( TTID , also known as MYOT ) detected a cytosine-to-thymine mutation in exon 2 of all clinically affected family members. Similar pathologic changes were present in all muscle biopsy specimens. Immunohistologic and biochemical analysis revealed that the TTID protein, also known as myotilin, is a component of the insoluble protein aggregate. Conclusions: A novel mutation in the TTID gene results in the clinical and pathologic phenotype termed “spheroid body myopathy.” Mutations in this gene also cause limb-girdle muscular dystrophy 1A and are associated with myofibrillar myopathy. |
Databáze: | OpenAIRE |
Externí odkaz: |